52 /100
HIGH RISK
Score updated Jul 13, 2026

RAPT — RAPT Therapeutics Inc Dilution Risk Tracker

Track RAPT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RAPT — Get alerts when the score changes →

As of July 13, 2026, RAPT Therapeutics Inc (RAPT) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. RAPT Therapeutics Inc has a market capitalization of $1.68B, 27.71M shares outstanding, 1 institutional holders tracked. Key dilution vectors include approximately 17 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for RAPT.
🔔 Track RAPT — Get forecast alerts →

💹 Market Data

Market Cap$1.68B
Shares Outstanding27.71M
Float16.85M
Cash$157.34M
Debt$2.60M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 80.1% shares (2026Q1 vs prior)
1 institutional holders · 589.0K shares
#1 BARCLAYS PLC 589.0K shares

📉 Short Interest

Short Interest1.78M
Days to Cover6.4
% of Float10.6%
FINRA data as of Jan 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2019
4 INSIDER TRANSACTION Mar 05, 2026
4 INSIDER TRANSACTION Mar 05, 2026
4 INSIDER TRANSACTION Mar 05, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for RAPT Shareholders

RAPT Therapeutics Inc (RAPT) has a DilutionScore of 52/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 13, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: RAPT has approximately 17 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for RAPT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for RAPT alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track RAPT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RAPT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

AGMH ALLR AMSS APC APRE

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for RAPT
📊 RAPT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 RAPT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.